BioCentury
ARTICLE | Politics & Policy

WHO updates HIV recommendations

July 2, 2013 12:35 AM UTC

The World Health Organization issued Gilead Sciences Inc. (NASDAQ:GILD) and Bristol-Myers Squibb Co. (NYSE:BMY) co-market tenofovir/emtricitabine/efavirenz as Atripla. ...